Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The company returns high margins, thereby supporting business profitability.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The firm trades with high earnings multiples: 30.81 times its 2021 earnings per share.

● With an enterprise value anticipated at 4.45 times the sales for the current fiscal year, the company turns out to be overvalued.

● The company appears highly valued given the size of its balance sheet.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.